Radiology-specific foundation model

Original Article ↗ Hacker News Discussion ↗

Overall reception

  • Many commenters are impressed by radiology-specific performance, especially on formal exams and radiograph tasks.
  • Others reserve judgment until third‑party validation and real‑world deployment data are available.
  • Some note this is far from the first “AI for radiology” effort; the commercial path is seen as the real difficulty.

Benchmarks, exams, and claims

  • Reported results on the FRCR 2B Rapids mock exam (radiographs only) are seen as strong; some ask if the model was trained on exam questions.
  • A developer states the model was not trained on FRCR questions and clarifies it only took a mock rapid‑reporting component, not the full exam, and that this has since been clarified on the site.
  • Comparisons to general multimodal LLMs (GPT‑4o, Gemini, Claude, etc.) are questioned because most weren’t trained specifically on diagnostic imaging.

Access, openness, and datasets

  • Several people can’t find a public model or code; access appears gated via a waitlist and eventual commercialization.
  • Commenters wish for an open, “LLaMA‑style” radiology foundation model; current open efforts are mostly narrow (e.g., lung cancer) or small research models.
  • Suggestions for datasets include TCGA/NCIA, DeepLesion, MIMIC CXR, and commercial vendors.

Clinical context and workflow

  • Radiologists stress that diagnosis is not pure image classification; patient demographics, history, and symptoms matter.
  • The model’s use of both images and chart data is praised as more realistic.
  • Multiple comments complain bitterly about RIS/PACS/EMR fragmentation and messy metadata; integration and data quality are seen as a larger barrier than model accuracy.
  • There is strong interest in tools that:
    • Auto‑structure dictations and reports.
    • Explain specific image regions with literature references.
    • Triage studies and reduce radiologist burnout.

Ethics, public access, and economics

  • One camp argues that restricting public access is largely greed; another cites safety, misdiagnosis, and system strain from “confidently wrong” self‑diagnosers.
  • Debate over whether access limits are “infantilization” vs necessary stewardship, with examples from different countries’ pharma and diagnostic access.
  • Concerns that AI may become another billable line item while justifying staff cuts and shifting liability.
  • Radiology remains highly competitive as a specialty; several argue AI is more likely to augment overworked radiologists than replace them soon.